dihexa clinical trial human trials status Dihexa shows neurotrophic activity exceeding BDNF in preclinical studies DIHEXA | Peptide Synthetic Dihexa 10mg | Peptide research

The information in this article is for educational purposes only and does not constitute medical advice

Practical and Research Context For researchers and readers using this page as reference material, the compounds sit at similar but not identical points: both are injectable, once-weekly, investigational metabolic peptides with genuine human RCT data a status that already sets them apart from the many research peptides supported only by animal or in-vitro work but neither is an approved medicine, and the two have never been compared directly

For non-standard ratios, use separate BPC-157 and TB-500 vials and adjust proportions yourself

[9] A separate small multicenter Phase II trial (registered as NCT01393132) in patients with severe dry eye reported significant improvements in both signs and symptoms versus vehicle control

Cognitive Impairment Models: Dihexa has been tested in scopolamine-induced amnesia models and aged rat models, where it demonstrated restoration of cognitive performance on spatial memory tasks